







The first medicine designed for children living with achondroplasia has been approved for use by the European Commission!
News



![[image description: collage of the rare bone disease study team's headshots]](/wp-content/uploads/2021/04/Meet-the-Rare-Bone-Disease-Study-Team-495x390.png)






MCDS-Therapy and Covid-19
News
Due to the current COVID-19 situation, we have had to make the difficult decision to halt the MCDS-Therapy study. This means that we are stopping study visits for the foreseeable future and all activity relating to the trial. Safety is…
MCDS-Therapy
MCDS-Therapy is an international collaboration to test a treatment for the rare skeletal dysplasia MCDS.
